At this point, most everyone has heard about GLP-1 drugs in the context of weight loss or diabetes. But scientists are now asking a different question: could these same medications help people drink less? A growing body of research suggests the answer may be yes, and not just for alcohol. New findings presented at the 49th annual scientific meeting of the Research Society on Alcohol point to GLP-1 receptor agonists as a potential treatment for alcohol use disorder (AUD), with implications that extend to other substance use disorders as well.
About the Author
